Skip to main content
Erschienen in: Supportive Care in Cancer 6/2009

01.06.2009 | Original Article

The Edmonton symptom assessment system—what do patients think?

verfasst von: Sharon Watanabe, Cheryl Nekolaichuk, Crystal Beaumont, Asifa Mawani

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Goals of work

The Edmonton Symptom Assessment System (ESAS) is a tool for self-reporting of symptom intensity, initially developed for advanced cancer patients. It consists of numerical rating scales for nine common symptoms, with the option of adding a tenth. Despite its widespread use in palliative care, few studies have focused on its psychometric properties, with none involving patient perspectives. The purpose of this study was to gather validity evidence for the ESAS, by examining patients’ cognitive processes while completing the ESAS, understanding of terminology and numerical ratings, and opinions of the ESAS as a self-reporting tool.

Materials and methods

English-speaking advanced cancer patients, referred to a Pain and Symptom Control Consultation Service in a cancer centre, were recruited. Using a qualitative “think aloud” study design, patients completed the ESAS independently while being prompted to verbalize their thoughts. They then answered a structured questionnaire to elicit their opinions of the ESAS. Transcripts of audio-taped sessions were coded and analyzed.

Main results

Twenty patients were evaluable. Symptom ratings were influenced by current symptom profiles, temporal changes, symptom experience history and individual perceptions. Symptom interpretation and numerical rating assignments varied. Difficult terminology included tiredness versus drowsiness, depression, anxiety, appetite, and well-being. Most patients agreed with the item order and thought that the ESAS was easy to complete, with a health care professional present. Patients expressed a need to emphasize the timeframe as “now”.

Conclusion

Modification of the tool and administration process may be warranted, but further study in other populations is needed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed
3.
Zurück zum Zitat Watanabe S, McKinnon S, Macmillan K, Hanson J (2006) Palliative care nurses’ perception of the Edmonton Symptom Assessment Scale: a pilot survey. Int J Palliat Nurs 12:111–114PubMed Watanabe S, McKinnon S, Macmillan K, Hanson J (2006) Palliative care nurses’ perception of the Edmonton Symptom Assessment Scale: a pilot survey. Int J Palliat Nurs 12:111–114PubMed
5.
Zurück zum Zitat Heedman PA, Strang P (2001) Symptom assessment in advanced palliative home care for cancer patients using the ESAS: clinical aspects. Anticancer Res 21:4077–4082PubMed Heedman PA, Strang P (2001) Symptom assessment in advanced palliative home care for cancer patients using the ESAS: clinical aspects. Anticancer Res 21:4077–4082PubMed
7.
Zurück zum Zitat Dudgeon DJ, Harlos M, Clinch JJ (1999) The Edmonton Symptom Assessment Scale (ESAS) as an audit tool. J Palliat Care 15:14–19PubMed Dudgeon DJ, Harlos M, Clinch JJ (1999) The Edmonton Symptom Assessment Scale (ESAS) as an audit tool. J Palliat Care 15:14–19PubMed
8.
Zurück zum Zitat Porzio G, Ricevuto E, Aielli F, Verna L, Cannita K, Pollice R, Aloisi P, Porto C, Marchetti P, Ficorella C (2005) The Supportive Care Task Force at the University of L’Aquila: 2-years experience. Support Care Cancer 13:351–355. doi:10.1007/s00520-004-0772-5 PubMedCrossRef Porzio G, Ricevuto E, Aielli F, Verna L, Cannita K, Pollice R, Aloisi P, Porto C, Marchetti P, Ficorella C (2005) The Supportive Care Task Force at the University of L’Aquila: 2-years experience. Support Care Cancer 13:351–355. doi:10.​1007/​s00520-004-0772-5 PubMedCrossRef
s11.
Zurück zum Zitat Nekolaichuk CL, Maguire TO, Suarez-Almazor M, Rogers WT, Bruera E (1999) Assessing the reliability of patient, nurse, and family caregivers symptom ratings in hospitalized advanced cancer patients. J Clin Oncol 17:3621–3630PubMed Nekolaichuk CL, Maguire TO, Suarez-Almazor M, Rogers WT, Bruera E (1999) Assessing the reliability of patient, nurse, and family caregivers symptom ratings in hospitalized advanced cancer patients. J Clin Oncol 17:3621–3630PubMed
13.
Zurück zum Zitat Davison SN, Jhangri GS, Johnson JA (2006) Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden. Kidney Int 69:1621–1625. doi:10.1038/sj.ki.5000184 PubMedCrossRef Davison SN, Jhangri GS, Johnson JA (2006) Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden. Kidney Int 69:1621–1625. doi:10.​1038/​sj.​ki.​5000184 PubMedCrossRef
15.
Zurück zum Zitat Moro C, Brunelli C, Miccinesi G, Fallai M, Morino P, Piazza M, Labianca R, Ripamonti C (2006) Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 14:30–37. doi:10.1007/s00520-005-0834-3 PubMedCrossRef Moro C, Brunelli C, Miccinesi G, Fallai M, Morino P, Piazza M, Labianca R, Ripamonti C (2006) Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 14:30–37. doi:10.​1007/​s00520-005-0834-3 PubMedCrossRef
16.
Zurück zum Zitat Bruera E, MacDonald S (2003) Audit methods: The Edmonton symptom assessment system. in: clinical audit in palliative care. Radcliffe Medical, Oxford, pp 61–77 Bruera E, MacDonald S (2003) Audit methods: The Edmonton symptom assessment system. in: clinical audit in palliative care. Radcliffe Medical, Oxford, pp 61–77
17.
Zurück zum Zitat Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Sjogren P (2002) Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer 38:788–794. doi:10.1016/S0959-8049(01)00470-1 PubMedCrossRef Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Sjogren P (2002) Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer 38:788–794. doi:10.​1016/​S0959-8049(01)00470-1 PubMedCrossRef
18.
Zurück zum Zitat Philip J, Smith WB, Craft P, Lickiss N (1998) Concurrent validity of the modified Edmonton symptom assessment system with the Rotterdam symptom checklist and the brief pain inventory. Support Care Cancer 6:539–541. doi:10.1007/s005200050212 PubMedCrossRef Philip J, Smith WB, Craft P, Lickiss N (1998) Concurrent validity of the modified Edmonton symptom assessment system with the Rotterdam symptom checklist and the brief pain inventory. Support Care Cancer 6:539–541. doi:10.​1007/​s005200050212 PubMedCrossRef
19.
Zurück zum Zitat Davison SN, Jhangri GS, Johnson JA (2006) Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant 21:3189–3195. doi:10.1093/ndt/gfl380 PubMedCrossRef Davison SN, Jhangri GS, Johnson JA (2006) Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant 21:3189–3195. doi:10.​1093/​ndt/​gfl380 PubMedCrossRef
22.
Zurück zum Zitat Patton MQ (2002) Qualitative research & evaluation methods (3rd ed.). Sage, Thousand Oaks Patton MQ (2002) Qualitative research & evaluation methods (3rd ed.). Sage, Thousand Oaks
23.
Zurück zum Zitat Anderson F, Downing GM, Hill J, Casorso L, Lerch N (1996) Palliative Performance Scale (PPS): a new tool. J Palliat Care 12:5–11PubMed Anderson F, Downing GM, Hill J, Casorso L, Lerch N (1996) Palliative Performance Scale (PPS): a new tool. J Palliat Care 12:5–11PubMed
27.
Zurück zum Zitat Messick S (1989) Validity. In: Educational measurement (3rd ed.). Oryx, Phoenix, pp 13–103 Messick S (1989) Validity. In: Educational measurement (3rd ed.). Oryx, Phoenix, pp 13–103
Metadaten
Titel
The Edmonton symptom assessment system—what do patients think?
verfasst von
Sharon Watanabe
Cheryl Nekolaichuk
Crystal Beaumont
Asifa Mawani
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2009
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0522-1

Weitere Artikel der Ausgabe 6/2009

Supportive Care in Cancer 6/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.